Le Lézard
Classified in: Health
Subjects: NPT, SVY, VET

New Analysis Highlights the Disproportionate Impact of Alzheimer's on Veterans


WASHINGTON, Oct. 2, 2017 /PRNewswire/ -- (There will be a media briefing today, October 2, at 2:00pm Eastern with leaders in the fight against Alzheimer's within the veteran community. Click here to join the livestream or dial 877-229-8493, PIN: 111049.)

A new UsAgainstAlzheimer's report, Veterans and Alzheimer's: Meeting the Crisis Head On, shows that Alzheimer's disease is both an urgent health care challenge among older veterans and a long-term threat to younger veterans. Each group faces unique Alzheimer's risk factors tied directly to their service, including post-traumatic stress, depression, traumatic brain injury, successive concussion syndrome, and blast-induced neurotrauma. This creates a clear and compelling obligation for increased research and greater access to high quality care to meet the needs of veterans with Alzheimer's and their families.

To answer this charge, UsAgainstAlzheimer's (UsA2) is launching VeteransAgainstAlzheimer's (VA2), a national network of veterans and their families, military leaders, veterans service organizations, researchers, and clinicians focused on raising awareness of the impact of Alzheimer's on active and retired service members and of the need for research and access to quality care.

"This is very personal to me. Love of country and support for our military is in my blood, and more than likely, so is Alzheimer's," said Shawn Taylor, Founder of VeteransAgainstAlzheimer's. "We all know what this disease looks like and the destruction it brings to the families. I'm on a mission to raise awareness and to educate the veteran community about Alzheimer's, and encourage these brave men and women to join with us to help stop this indiscriminate disease."

According to the report, age is the top known risk factor for Alzheimer's, and that risk increases greatly after age 65. Nearly 50 percent of veterans are age 65 or older and therefore at heightened risk for Alzheimer's, compared to 15 percent of the general population. Furthermore, studies show that older veterans who have suffered a traumatic brain injury are 60 percent more likely to develop dementia. Twenty-two percent of all combat wounds in Afghanistan and Iraq were brain injuries, nearly double the rate seen during Vietnam ? increasing these younger veterans' lifetime Alzheimer's risk.

In addition:

"The VFW knows that this is a major issue for veterans ? especially when data indicates that the risks associated with military service make veterans more likely to develop Alzheimer's and other forms of dementia," said Bob Wallace, Executive Director, Veterans of Foreign Wars of the United States. "Through VeteransAgainstAlzheimer's, we have the opportunity to bring together leading voices in the veteran community to promote brain health through action, research, and improved care."

Veterans face barriers to effective Alzheimer's diagnosis and care, including a complex VA health system, a lack of understanding about available benefits, and a stigma related to brain and mental health.

"My husband, Jim, retired after 23 years in the Air Force and thought he would be able to get help with his Younger Onset Alzheimer's Disease. But we were left to our own devices for non-medical help and assisted living," said Karen Garner, caregiver to James B. Garner, Senior Master Sergeant, USAF (Ret.) and author of Missing Jim: Confessions of an Alzheimer's Wife. "We must work towards not only a cure but making sure those who have served and protected us are protected themselves."

Click here for the full report and here for additional quotes about VeteransAgainstAlzheimer's.

UsAgainstAlzheimer's (UsA2) is an innovative non-profit organization demanding ? and delivering ? a solution to Alzheimer's. Driven by the suffering of millions of families, UsAgainstAlzheimer's presses for greater urgency from government, industry and the scientific community in the quest for an Alzheimer's cure ? accomplishing this through effective leadership, collaborative advocacy, and strategic investments.

Contact: Jeannette O'Connor
202-302-3268
[email protected]          

SOURCE UsAgainstAlzheimer's


These press releases may also interest you

at 22:33
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

at 22:03
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

at 21:27
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...

at 19:30
Astellas Pharma Inc....

at 19:15
Denver nonprofit Justice Necessary unveils data from its latest study on teen period poverty in Colorado, shedding light on a deeply concerning issue. The findings of this study underscore the urgent need for action to address the need for teens to...

at 19:05
Xaira Therapeutics launched today on a mission to help re-engineer the way we discover and develop medicines through the end-to-end application of emerging AI technologies. A joint incubation by ARCH Venture Partners and Foresite Labs, Xaira launched...



News published on and distributed by: